by Marina Chenery | Sep 21, 2021 | News
Optibrium appoints Professor Andy Black as non-executive Chair Appointment brings extensive pharmaceutical services and Board experience to drive commercial growth and development of new products to improve speed, efficiency, and productivity of drug discovery ...
by Marina Chenery | Sep 15, 2021 | Webinars
3D Ligand-Based Drug Design: webinar In this webinar, we demonstrate intuitive workflows for 3D ligand-based drug design, allowing you to;• Enable 3D design, even with little or no target structure information• Find novel active compounds with 3D virtual screening...
by Marina Chenery | Sep 9, 2021 | News
Optibrium Releases 3D Ligand-based Design Modulefor StarDrop Drug Discovery Software Innovative predictive methods support virtual screening and compound design in the absence of 3D structure data. CAMBRIDGE, UK, 9 September 2021 – Optibrium Limited, a developer of...